Key Market Indicator:
F&G: 23
25.215,70 NASDAQ · 47.521,00 DOW · 6.798,75 S&P · 4.239,07 Gold · 63,49 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
DE0005664809
Filter zurücksetzen
© EQS Newswire
30.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital und Inserm Transfert arbeiten zusammen, um neue therapeutische Ziele bei Adipositas und Stoffwechselerkrankungen zu identifizieren
Article
News Preview
  Partnerschaft wird Evotecs molekulare Patientendatenbank im Bereich Stoffwechselerkrankungen und insbesondere Adipositas erweitern Evotec wird ihre führende PanOmics-Technologie für die Generierung von großen Omics-Datensätzen, einschließlich Transkriptomik, Proteomik und Metabolomik, einsetzen Lille University Hospital wird biologi......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
Article
News Preview
  Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics Lille University Hospital will provide human biological samp......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
Article
News Preview
  Partnership will expand Evotec’s molecular patient database in the area of metabolic diseases and in particular obesity Evotec will leverage its leading PanOmics technologies for the generation of large omics data sets including transcriptomics, proteomics and metabolomics Lille University Hospital will provide human biological samp......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© EQS Newswire
28.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec und CHDI Foundation verlängern strategische Huntington-Allianz
Article
News Preview
  Langjährige Allianz zwischen Evotec und CHDI zur Entwicklung von Therapeutika für die Huntington-Krankheit Eine der größten strategischen Wirkstoffforschungs-Allianzen von Evotec   Hamburg, 28. Mai 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute die Verlängerung ihrer 20......
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© EQS Newswire
28.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
Article
News Preview
  Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease One of Evotec’s largest strategic drug discovery alliances   Hamburg, Germany, 28 May 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
28.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease
Article
News Preview
  Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease One of Evotec’s largest strategic drug discovery alliances   Hamburg, Germany, 28 May 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Ergebnisse für das erste Quartal 2024 und Update zur Unternehmensentwicklung
Article
News Preview
HERAUSFORDERNDES Q1 2024 MIT SCHWÄCHEN DES TRANSAKTIONALEN-/ DEVELOPMENT-GESCHÄFTS IN SHARED R&D GEGENÜBER EINEM STARKEN VERGLEICHSQUARTAL STARKER START VON JUST – EVOTEC BIOLOGICS IN Q1 2024 POSITIVE DYNAMIK IM AUFTRAGSBESTAND VON SHARED R&D DISCOVERY DEUTET AUF ERHOLUNG DES UMSATZES ZUM JAHRESENDE HIN NEUAUSRICHTUNG AUF PROFITABLES WAC......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec reports Q1 2024 results and provides corporate update
Article
News Preview
CHALLENGING Q1 WITH SOFTNESS MAINLY IN TRANSACTIONAL/DEVELOPMENT SHARED R&D BUSINESS AGAINST A STRONG COMPARABLE QUARTER STRONG START WITH JUST – EVOTEC BIOLOGICS IN Q1 2024 POSITIVE MOMENTUM IN SHARED R&D DISCOVERY CLOSED SALES POINT TO RECOVERY OF REVENUES TOWARDS END OF THE YEAR RESET FOR PROFITABLE GROWTH INITIATED, NEW REPORTING SEG......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das erste Quartal 2024 am 22. Mai 2024
Article
News Preview
Hamburg, 15. Mai 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 22. Mai 2024, ihren Bericht über das erste Quartal 2024. In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Berichtszeitraum näher erläutert. Außerdem wird über......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das erste Quartal 2024 am 22. Mai 2024
Article
News Preview
Hamburg, 15. Mai 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 22. Mai 2024, ihren Bericht über das erste Quartal 2024. In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Berichtszeitraum näher erläutert. Außerdem wird über......
Themefolio
Profiler
Peergroup
© EQS Newswire
15.05.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE to announce results for first quarter 2024 on 22 may 2024
Article
News Preview
Hamburg, Germany, 15 May 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first quarter of 2024 on Wednesday, 22 May 2024. The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bayer and Evotec collaborate to advance precision cardiology
Article
News Preview
BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASES STRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETS JOINT EFFORT AIMS TO DEVELOP INNOVATIVE THERAPIES IN PRECISION CARDIOLOGY   Berlin and Hamburg, Germany, 30 April 2024: Bayer and the German-based l......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© EQS Newswire
30.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bayer und Evotec vereinbaren Forschungskollaboration in der Präzisionskardiologie
Article
News Preview
DIE BAYER UND EVOTEC ERWEITERN DEN FOKUS IHRER ZUSAMMENARBEIT AUF HERZ-KREISLAUF-ERKRANKUNGEN STRATEGISCHE ALLIANZ NUTZT DIE MODELLIERUNG VON KRANKHEITEN DURCH MENSCHLICHE INDUZIERTE PLURIPOTENTE STAMMZELLEN ZUR IDENTIFIZIERUNG NEUER WIRKSTOFFZIELE GEMEINSAME ANSTRENGUNGEN ZIELEN AUF DIE ENTWICKLUNG INNOVATIVER THERAPIEN IN DER PRÄZISIONSKARDIOLO......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bayer und Evotec vereinbaren Forschungskollaboration in der Präzisionskardiologie
Article
News Preview
DIE BAYER UND EVOTEC ERWEITERN DEN FOKUS IHRER ZUSAMMENARBEIT AUF HERZ-KREISLAUF-ERKRANKUNGEN STRATEGISCHE ALLIANZ NUTZT DIE MODELLIERUNG VON KRANKHEITEN DURCH MENSCHLICHE INDUZIERTE PLURIPOTENTE STAMMZELLEN ZUR IDENTIFIZIERUNG NEUER WIRKSTOFFZIELE GEMEINSAME ANSTRENGUNGEN ZIELEN AUF DIE ENTWICKLUNG INNOVATIVER THERAPIEN IN DER PRÄZISIONSKARDIOLO......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth
Article
News Preview
FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M EVOTEC’S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS “SHARED R&D” AND “JUST – EVOTEC BIOLOGICS” STARTING Q1 2024 Hamburg, Germany, 24 April 202......
Themefolio
Profiler
Peergroup
© EQS Newswire
24.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE stellt Ergebnisse für das Geschäftsjahr 2023 vor und richtet Priorität auf profitables Wachstum aus
Article
News Preview
FINANZERGEBNIS 2023 ERREICHT IN ALLEN PUNKTEN DIE AKTUALISIERTE PROGNOSE NEUAUSRICHTUNG DER PRIORITÄT AUF PROFITABLES WACHSTUM: ANPASSUNGEN BEI GRÖẞE UND STANDORTEN, UM JÄHRLICHEN EBITDA-BEITRAG VON MEHR ALS 40 MIO. € ZU ERREICHEN EVOTECS BERICHTSSTRUKTUR VERÄNDERT SICH MIT DEM ERSTEN QUARTAL 2024 ZU DEN SEGMENTEN “SHARED R&D” UND “JUST – EVO......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer
Article
News Preview
Hamburg, 23. April 2024: Der Aufsichtsrat der Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) hat Dr. Christian Wojczewski mit Wirkung zum 1. Juli 2024 zum Chief Executive Officer („CEO“) von Evotec ernannt. Die Wahl erfolgte einstimmig und ist das Ergebnis eines im Januar 2024 begonnen umfassenden Auswahl......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Article
News Preview
Hamburg, Germany, 23 April 2024: The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has appointed Dr Christian Wojczewski as the Company’s new Chief Executive Officer (“CEO”), effective 01 July 2024. The election was unanimous and is the result of an extensive selection process that bega......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer
Article
News Preview
Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces the appointment of Dr Christian Wojczewski as Chief Executive Officer of the Company, effective 01 July 2024. Dr Wojczewski holds a degree in chemistry and has over 20 years of experience in various man......
Themefolio
Profiler
Peergroup
© EQS Newswire
23.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE ernennt Dr. Christian Wojczewski zum Chief Executive Officer
Article
News Preview
Hamburg, Deutschland – Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) gibt die Ernennung von Dr. Christian Wojczewski zum Chief Executive Officer („CEO“) von Evotec mit Wirkung zum 1. Juli 2024 bekannt. Dr. Wojczewski ist studierter Chemiker mit über 20 Jahren Erfahrung in u......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec und Variant Bio gehen strategische Partnerschaft zur Entdeckung und Entwicklung von Fibrose-Behandlungen ein
Article
News Preview
  DIE KOLLABORATION NUTZT VARIANT BIOS HOCHMODERNE GENOMIK-FORSCHUNGSPLATTFORM UND EVOTECS INTEGRIERTE END-TO-END F&E-PLATTFORM UND EXPERTISE IM KRANKHEITSBEREICH, UM UNGEDECKTEN MEDIZINISCHEN BEDARF IN FIBROTISCHEN INDIKATIONEN ANZUGEHEN DIE KOMMERZIELLEN BEDINGUNGEN UMFASSEN FORSCHUNGSZAHLUNGEN SOWIE MEILENSTEINE UND/ODER UMSATZBETEILIGUNGE......
Themefolio
Profiler
Peergroup
© EQS Newswire
18.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments
Article
News Preview
  COLLABORATION LEVERAGES VARIANT BIO’S CUTTING-EDGE GENOMIC DISCOVERY PLATFORM AND EVOTEC’S INTEGRATED END-TO-END R&D PLATFORM AND DISEASE AREA EXPERTISE TO ADDRESS UNMET MEDICAL NEED IN FIBROTIC INDICATIONS COMMERCIAL TERMS INCLUDE RESEARCH FUNDING AND MILESTONES AND/OR ROYALTY PAYMENTS TO EVOTEC BASED ON THE OVERALL SUCCESS OF THE PROGRAMM......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec SE to announce results for fiscal year 2023 on 24 April 2024
Article
News Preview
Hamburg, Germany, 17 April 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for 2023 on Wednesday, 24 April 2024. The Company is going to hold a conference call to discuss the results as well as provide an update on its performance. The conference call will be held in ......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Bekanntgabe der Ergebnisse für das Geschäftsjahr 2023 am 24. April 2024
Article
News Preview
  Hamburg, 17. April 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 24. April 2024, ihren Bericht über das Geschäftsjahr 2023. In einer Telefonkonferenz in englischer Sprache werden die Ergebnisse und Schwerpunkte aus dem Berichtszeitraum näher erläutert. Außerdem wi......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec welcomes Aurélie Dalbiez as Chief People Officer
Article
News Preview
Hamburg, Germany, 17 April 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced the appointment of Aurélie Dalbiez as the Company’s new Chief People Officer (“CPO”), effective 15 June 2024. Aurélie will be joining Evotec’s Management Board, bringing with her a wealth of experience and experti......
Themefolio
Profiler
Peergroup
© EQS Newswire
17.04.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec heißt Aurélie Dalbiez als Chief People Officer willkommen
Article
News Preview
Hamburg, 17. April 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute die Ernennung von Aurélie Dalbiez als neue Chief People Officer („CPO“) des Unternehmens mit Wirkung zum 15. Juni 2024 bekannt. Als neues Vorstandsmitglied wird Aurélie eine Fülle von Erfahrungen und Fachwissen im Bereich de......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.03.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic
Article
News Preview
CLARIS’S PORTFOLIO COMPANIES RECEIVE EASY ACCESS TO EVOTEC’S FULL RANGE OF PRE-CLINICAL AND CLINICAL DEVELOPMENT AND MANUFACTURING CAPABILITIES AGREEMENT BUILDS ON SUCCESSFUL COLLABORATION BETWEEN EVOTEC AND CLARIS’S PORTFOLIO COMPANY IAMA   Hamburg, Germany, and Turin, Italy, 06 March 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.03.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec und Claris Ventures kooperieren, um Programme von Claris' Portfoliounternehmen in die Klinik zu beschleunigen
Article
News Preview
CLARIS‘ PORTFOLIOUNTERNEHMEN ERHALTEN EINFACHEN ZUGANG ZU EVOTECS UMFASSENDEM ANGEBOT AN PRÄKLINISCHEN UND KLINISCHEN ENTWICKLUNGS- UND PRODUKTIONSKAPAZITÄTEN DIE VEREINBARUNG BAUT AUF EINER ERFOLGREICHEN ZUSAMMENARBEIT ZWISCHEN EVOTEC UND CLARIS‘ PORTFOLIOUNTERNEHMEN IAMA AUF   Hamburg, Deutschland, und Turin, Italien, 06. März 2024: Evotec SE (......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.02.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Just – Evotec Biologics expands development and manufacturing agreement with ABL for broadly neutralising antibodies against HIV
Article
News Preview
JUST – EVOTEC BIOLOGICS TO PROVIDE DEVELOPMENT AND PHASE I CLINICAL MANUFACTURING OF BROADLY NEUTRALISING ANTIBODY AGAINST HIV  AGREEMENT BUILDS ON PREVIOUS NIAID-FUNDED COLLABORATION TO DEVELOP A BROADLY NEUTRALISING ANTIBODY AGAINST HIV Hamburg, Germany, 07 February 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809;......
Themefolio
Profiler
Peergroup
© EQS Newswire
07.02.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Just – Evotec Biologics erweitert Kooperation mit ABL zur Entwicklung und Herstellung breit neutralisierender Antikörper gegen HIV
Article
News Preview
JUST – EVOTEC BIOLOGICS WIRD BREIT NEUTRALISIERENDE ANTIKÖRPER GEGEN HIV ENTWICKELN UND FÜR EINE KLINISCHE PHASE-I-STUDIE HERSTELLEN VEREINBARUNG BAUT AUF VORHERIGER VON NIAID FINANZIERTER KOOPERATION ZUR ENTWICKLUNG EINES BREIT NEUTRALISIERENDEN ANTIKÖRPERS GEGEN HIV AUF Hamburg, 07. Februar 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Invitation to Conference Call
Article
News Preview
Hamburg, Germany, 22 January 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) is going to hold a conference call to provide a statement as well as a business update on Monday, 22 January 2024. During the call, the Chairwoman of Evotec’s Supervisory Board, Prof. Iris Löw-Friedrich and Evotec’s CEO Dr Mari......
Themefolio
Profiler
Peergroup
© EQS Newswire
22.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Einladung zu Telefonkonferenz
Article
News Preview
Hamburg, 22. Januar 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) wird am Montag, den 22. Januar 2024, eine Telefonkonferenz abhalten, um eine Stellungnahme abzugeben und über die aktuelle Geschäftsentwicklung zu berichten. Im Rahmen der Telefonkonferenz werden die Vorsitzende des Aufsichtsrats......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies
Article
News Preview
EVOTEC JOINS FORCES WITH THE CROHN’S & COLITIS FOUNDATION’S IBD THERAPEUTICS INCUBATOR TO ADVANCE DRUG DISCOVERY AND IDENTIFY NOVEL THERAPIES FOR INFLAMMATORY BOWEL DISEASE (“IBD”) THE COLLABORATION LEVERAGES EVOTEC'S END-TO-END INTEGRATED R&D PLATFORM TO ADVANCE DRUG DISCOVERY FOR TWO INNOVATIVE DRUG TARGETS ADDRESSING FIBROSIS AND IMPAIR......
Themefolio
Profiler
Peergroup
© EQS Newswire
10.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec und Crohn´s & Colitis Foundation gehen Vereinbarung zur Förderung der Wirkstoffforschung für neue IBD Therapien ein
Article
News Preview
EVOTEC SCHLIESST SICH MIT DEM IBD THERAPEUTICS INCUBATOR PROGRAMM DER CROHN’S & COLITIS FOUNDATION ZUSAMMEN, UM DIE WIRKSTOFFFORSCHUNG FÜR ENTZÜNDLICHE DARMERKRANKUNGEN („IBD“) VORANZUTREIBEN UND NEUE THERAPIEANSÄTZE ZU IDENTIFIZIEREN DIE KOLLABORATION NUTZT EVOTECS INTEGRIERTE END-TO-END F&E-PLATTFORM, UM DIE WIRKSTOFFFORSCHUNG FÜR ZWEI I......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec verkündet Fortschritt in strategischer Neurologie-Partnerschaft mit Bristol Myers Squibb
Article
News Preview
WICHTIGER WISSENSCHAFTLICHER FORTSCHRITT BRINGT DIE GEMEINSAME NEUROLOGIE-PIPELINE VORAN UND LÖST EINE ZAHLUNG VON 25 MIO. $ AN EVOTEC AUS, UM DIE WEITERE FORSCHUNG VORANZUTREIBEN   Hamburg, 08. Januar 2024: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute einen Fortschritt in der strategischen P......
Themefolio
Profiler
Peergroup
© EQS Newswire
08.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
Article
News Preview
KEY SCIENTIFIC ACHIEVEMENT ADVANCES THE JOINT NEUROSCIENCE PIPELINE AND EARNS A PAYMENT OF US$ 25 M TO EVOTEC TO PROGRESS FURTHER RESEARCH   Hamburg, Germany, 08 January 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced progress within the Company’s strategic partnership with Bristol Myer......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec und Owkin gehen K.I.-gestützte strategische Partnerschaft zur Beschleunigung der therapeutischen Pipeline in den Bereichen Onkologie und I&I ein
Article
News Preview
PARTNERSCHAFT KOMBINIERT OWKINS FÄHIGKEITEN ZUR K.I.-GESTÜTZTEN ENTDECKUNG VON TARGETS MIT EVOTECS INTEGRIERTEN SHARED END-TO-END FORSCHUNGS- & ENTWICKLUNGS-PLATTFORM K.I.-GESTÜTZTE PLATTFORMEN WERDEN OWKINS NEUARTIGE PROGRAMME VON DER ENTDECKUNGSPHASE IN DIE KLINISCHE ENTWICKLUNG BESCHLEUNIGEN VEREINBARUNG UMFASST ERFOLGSABHÄNGIGE MEILENSTEI......
Themefolio
Profiler
Peergroup
© EQS Newswire
04.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I
Article
News Preview
PARTNERSHIP COMBINES OWKIN’S A.I. TARGET DISCOVERY CAPABILITIES WITH EVOTEC’S INTEGRATED END-TO-END SHARED R&D PLATFORM A.I.-POWERED PLATFORMS WILL ACCELERATE OWKIN’S NOVEL PROGRAMMES FROM THE DISCOVERY PHASE TO THE CLINIC AGREEMENT INCLUDES SUCCESS-BASED MILESTONES AND ROYALTY PAYMENTS TO EVOTEC  Hamburg, Germany, and Paris, France, 04 Janu......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec gibt CEO-Wechsel bekannt
Article
News Preview
DR. WERNER LANTHALER TRITT ALS VORSTANDSVORSITZENDER (CEO) ZURÜCK STEHT DEM AUFSICHTSRAT WEITERHIN ALS STRATEGISCHER BERATER ZUR VERFÜGUNG, UM EINE REIBUNGSLOSE ÜBERGABE ZU GEWÄHRLEISTEN DR. MARIO POLYWKA HAT ZUGESTIMMT, DAS AMT ALS CEO INTERIMISTISCH ZU ÜBERNEHMEN SUCHE FÜR EINEN LANGFRISTIGEN CEO GESTARTET, UM DEN AUFBAU DES WELTWEIT FÜHRENDEN......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec announces CEO transition
Article
News Preview
DR WERNER LANTHALER TO STEP DOWN AS CEO REMAINS AVAILABLE AS STRATEGIC ADVISOR TO THE SUPERVISORY BOARD TO FACILITATE A SMOOTH TRANSITION DR MARIO POLYWKA HAS AGREED TO STEP IN AS INTERIM CEO SEARCH STARTED FOR PERMANENT CEO TO CONTINUE BUILDING THE GLOBALLY LEADING COMPANY FOR EXTERNAL INNOVATION EVOTEC CONFIRMS GUIDANCE 2023 Hamburg, Germany......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec gibt CEO-Wechsel bekannt
Article
News Preview
Hamburg, Deutschland, – Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) gibt bekannt, dass Vorstandsvorsitzender Dr. Werner Lanthaler dem Unternehmen mitgeteilt hat, dass er aus persönlichen Gründen als CEO zurücktritt und seinen Vertrag nicht bis zum Ende der aktuellen Laufz......
Themefolio
Profiler
Peergroup
© EQS Newswire
03.01.2024
ISIN: DE0005664809
Evotec SE
EVT
LISTED
XETR
Evotec announces CEO transition
Article
News Preview
Hamburg, Germany, – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) announces that CEO Dr Werner Lanthaler has informed the company, that he has decided to step down as CEO and will not continue to serve until the end of his current term, for personal reasons. The Supervisory Bo......
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 01.12.2025, Calendar Week 49, 335th day of the year, 30 days remaining until EoY.